Fundraising Fox

Vascugen

Madison, US · Founded 2017 · 1 known investors

vascugen.com ↗

Vascugen develops cell therapies based on induced pluripotent stem cell (iPSC) technology and a proprietary cell differentiation process to restore blood flow in tissues affected by ischemia. The company works in regenerative medicine, targeting patients with degenerative conditions caused by loss of blood flow.

BiotechHealthtechLongevity

Founders & leadership

MY
Marvin YoderDirector
CC
Carter CliffExecutive Officer, Director
TN
Tom NovakDirector
JK
Jeffrey KennedyDirector

Investors · 1

IU VenturesBloomington

Reported raises · per SEC filings

Form D private placements
▶$10MraisedAug 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marvin YoderDirector
  • Carter CliffExecutive Officer, Director
  • Tom NovakDirector
  • Jeffrey KennedyDirector
Offering amount
$10M
Amount sold
$10M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.